Some clinics now market injections for quick cosmetic weight loss, including pre-wedding programs
On May 9, 2024, significant advancements were made in the Ozempic multidistrict litigation (MDL), currently underway in Philadelphia
To understand the hype, we have to look at the science
The model was first fitted to the training concentrations (37.5 and 25 M doxorubicin), and then used to simulate the test concentrations (50, 12.5 and 10 M doxorubicin) as a means of blind validation, showing good accordance between the experimental and in silico outputs for all concentrations of doxorubicin
The two co-primary endpoints were analyzed independently, requiring statistical superiority for both to demonstrate a significant benefit of semaglutide versus placebo
Call us today and lets talk!